Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZVS203e Injection for RHO p.R135W Retinitis Pigmentosa (Single-arm Open-label Phase I/II Study)
CTR20251791Phase 2Active
- Sponsor
- Beijing Sino-Cause Pharmaceutical
- Start
- May 2025
- Modality
- Gene Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of ZVS203e in retinitis pigmentosa (RP), sponsored by Beijing Sino-Cause Pharmaceutical. Started May 2025; status: active.
02
Drugs
ZVS203e
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on CTR20251791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251791.